Protagonist Therapeutics, Inc. Skyrocketed

Tue, Mar 07, 2023 at 07:10 PM
Protagonist Therapeutics, Inc. Skyrocketed

Protagonist Therapeutics, Inc. (PTGX:NASDAQ) shot up at $23.09, representing a gain of 51.9%. On Tue, Mar 07, 2023, PTGX:NASDAQ touched a New 2-Week High of $23.09. The stock got featured on our News Catalysts scanner on Tue, Mar 07, 2023 at 09:23 AM in the 'BIOTECH' category. From Tue, Feb 21, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days

About Protagonist Therapeutics, Inc. (PTGX:NASDAQ)

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary peptide-based technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.